ClinConnect ClinConnect Logo
Search / Trial NCT06543329

Comparative Analysis of Subcuticular Suture Materials in Cesarean Section

Launched by CAIRO UNIVERSITY · Aug 6, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Cesarean Section Wound Complication Obesity Monocryl Vicryl Prolene Polyester

ClinConnect Summary

This clinical trial is studying different types of materials used for stitching up the skin after a cesarean section (C-section). The goal is to find out which suture material leads to fewer problems with healing and better cosmetic results, such as how the scar looks after the surgery. This is important because choosing the right material can help prevent complications and improve recovery for new mothers.

To participate in this study, women aged 20 to 45 who are having their first or second C-section may be eligible. They should also have a body mass index (BMI) of 40 or higher and a healthy pregnancy without any serious medical conditions. Participants can expect to be monitored for any healing issues and how their incision looks after the procedure. It's important to note that women with certain infections, medical conditions, or previous complications may not qualify for the study.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Women aged 20-45 years old.
  • 2. BMI = or more than 40 kg/m2
  • 3. Primigravida or not more than the previous 1 cesarean section.
  • 4. Will undergo a lower-segment cesarean section.
  • 5. Hb: ≥ 10 gm/dl.
  • 6. Viable fetus.
  • 7. No history of medical comorbidities.
  • Exclusion Criteria:
  • 1. History of urogenital tract infection within 2 weeks before cesarean delivery.
  • 2. Presence of clinical signs of infection at the time of delivery including PPROM and intraamniotic infection.
  • 3. Medical comorbidities (hypertension, diabetes, etc.).
  • 4. Hypersensitivity to any of the suture materials.
  • 5. Women with abnormal placentation (placental abruption or placenta previa).
  • 6. History of systemic corticosteroid intake during their pregnancy for 2 weeks or more.
  • 7. History of previous surgical site infection.
  • 8. Immune-compromised women.
  • 9. Women refused to participate in the study or could not obtain consent.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Ahmed N Afifi, MD

Principal Investigator

Kafrelsheikh University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported